The Pulse by Wharton Digital Health

Clara Burtenshaw, Neo Kuma Ventures, on shattering the stigma of psychedelic medication

Clara Burtenshaw, Neo Kuma Ventures, on shattering the stigma of psychedelic medication

In this episode, we sat down with Clara Burtenshaw, Partner and Investor at Neo Kuma Ventures. We discussed: -The evolution of the psychedelics industry from a stigmatized counterculture phenomenon to a scientifically robust industry with support from the FDA for fast-tracking drug development -The clinical potential of psychedelics to treat illnesses ranging from mental illness to pain management and other nervous system disorders -Neo Kuma's focus on investing in early stage companies backed by sound science and building a strong founder network -Predictions that psychedelics as medication is here to stay, and the growing commercialization opportunities in the space

Duration: 58 min

Release Date:

Share part or all of the audio of this episode